Shield by Guardant vs Oncotype DX

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Shield by Guardant

FDA approved (CRC test only)
$1495

Colorectal only

Oncotype DX

Guideline recommended
Variable

Breast recurrence risk

Test Performance

FeatureShield by GuardantOncotype DX
Price$1495Variable
Cancers DetectedColorectal onlyBreast recurrence risk
Sensitivity83% for CRC (54.5-65% Stage I)N/A
Specificity90%N/A
Sample TypeBlood drawTumor tissue
FDA StatusFDA approved (CRC test only)Guideline recommended

Get monthly price updates &deals

We track pricing changes across 50+ health testing providers so you don't have to.

Free, once a month. No spam.